Eric Deneault is a research scientist at Health Canada. He received his BSc in biotechnology from the University of Sherbrooke, Canada, and his MSc in veterinary sciences and PhD in molecular biology from the University of Montreal. He then joined the Hospital for Sick Children, Toronto, Canada as a postdoctoral researcher in genetics before joining Dr. Durcan’s group at the Montreal Neurological Institute, McGill University, Canada, as a research associate in the Early Drug Discovery Unit (EDDU). In his current research, Dr. Deneault uses CRISPR gene-editing and induced pluripotent stem cells as a model to study the genetic variants involved in various neurological pathologies, including autism spectrum disorder and Parkinson’s disease.